# Dexamethasone vs Dexmedetomidine for iPACK + ACB in TKA

> **NCT07386600** · NA · RECRUITING · sponsor: **Poznan University of Medical Sciences** · enrollment: 96 (estimated)

## Conditions studied

- Knee Osteoarthritis

## Interventions

- **DRUG:** Ropivacaine 0.2% Injectable Solution
- **DRUG:** Dexamethasone 4mg
- **DRUG:** Dexmedetomidine

## Key facts

- **NCT ID:** NCT07386600
- **Lead sponsor:** Poznan University of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-01-01
- **Primary completion:** 2027-01-01
- **Final completion:** 2027-01-31
- **Target enrollment:** 96 (ESTIMATED)
- **Last updated:** 2026-02-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07386600

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07386600, "Dexamethasone vs Dexmedetomidine for iPACK + ACB in TKA". Retrieved via AI Analytics 2026-09-08 from https://api.ai-analytics.org/clinical/NCT07386600. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*